Task: Please answer the following question about the molecule with SMILES CNC1CN(c2cc(N)nc(CC(C)C)n2)C1.
Request: Please describe this drug.
Answer: Seliforant is under investigation in clinical trial NCT01260753 (Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge).
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CNC1CN(c2cc(N)nc(CC(C)C)n2)C1
CC(C)CC1=NC(=CC(=N1)N2CC(C2)NC)N
6-[3-(methylamino)azetidin-1-yl]-2-(2-methylpropyl)pyrimidin-4-amine
Please describe this drug.
Seliforant is under investigation in clinical trial NCT01260753 (Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge).